Clinical Trial

Oxyhydrogen Nanobubble Infusion as a Complementary Therapy in Patients With Parkinsonism

Name: Oxyhydrogen Nanobubble Infusion as a Complementary Therapy in Patients With Parkinsonism — clinical trial record (NCT07466381)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: OHNB

Completed Phase 2/3

View on ClinicalTrials.gov →

Summary

The aim of this study was to determine the effect of oxyhydrogen nanobubble infusion on the degree of disease, cognitive function, and quality of life of patients with parkinsonism

Trial Details

NCT Number	NCT07466381
Lead Sponsor	dr. Siti Nurlaela, SpN
Conditions	Parkinson Disease
Enrollment	35 participants
Start Date	2024-11-01
Primary Completion	2025-11-30 (estimated)
Study Completion	2026-01-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-12